ChemInform Abstract: Antiretroviral Therapy of the HIV-Infection
β Scribed by Juergen Kurt Rockstroh
- Publisher
- John Wiley and Sons
- Year
- 2000
- Weight
- 24 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0931-7597
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The emergence of mutations encoding drug resistance is supposed to be a significant limitation to the clinical efficacy of inhibitor compounds directed against specific HIV-1 enzymatic targets. We have used a commercial test (Visible Genetics Inc., Paris, France) to study the prevalence of mutations
Despite the high frequency of HCV and HIV coinfection, little is known about HCV quasispecies in HIV-positive patients. The current analysis included 236 HIV+/anti-HCV+ women enrolled in the Women's Interagency HIV Study (WIHS). Hypervariable region 1 of the second envelope gene was analyzed by sing
## Abstract The effect of highly active antiretroviral therapy (HAART) on survival in HIVβinfected patients with Kaposi sarcoma (KS) or nonβHodgkin lymphoma (NHL) is unknown. Our study examines survival after HAART for these 2 malignancies. Analyses were performed using data from 387 HIVβinfected m
## Abstract ## Background Despite the correlation between the use of protease inhibitors (PI) and adverse metabolic glycemic events, no prospective study has examined these parameters in pregnant women who use these drugs. ## Methods A prospective study was conducted on 57 pregnant women to inve